アジア太平洋地域の抗うつ薬市場は2023年に約41億7,000万米ドルと評価され、2024年から2032年の予測期間にわたって3.55%を超える健全な成長率で成長すると予想されています。
抗うつ薬は、うつ病や不安症、強迫性障害などの症状の治療に役立つ一般的な処方薬です。医療従事者は、うつ病やその他の精神状態などの症状の治療に抗うつ薬を処方します。これらの薬は、脳内のノルエピネフリンやセロトニンなどの特定の化学物質のレベルに影響を与えることで作用します。さらに、アジア太平洋地域の多くの国でメンタルヘルスの問題に対する意識が高まっており、アジア太平洋地域の抗うつ薬市場における抗うつ薬を含むメンタルヘルスサービスと治療の需要につながっています。
アジア太平洋地域の抗うつ薬市場は、医療費の増加によって牽引されており、地域全体で抗うつ薬を含む医療サービスや医薬品へのアクセスが向上しています。さらに、アジア太平洋地域でうつ病やその他の精神疾患などの精神疾患の有病率の上昇と、この地域の高齢者人口の増加が、抗うつ薬の需要を促進しています。さらに、この地域での政府支援の増加と医薬品承認活動の増加は、市場の成長に新たな機会を生み出しています。ただし、この地域での代替治療モードの利用可能性と償還ポリシーの制限により、2024年から2032年の予測期間中、市場全体の需要が妨げられることになります。
アジア太平洋地域の抗うつ薬市場調査で検討されている主要国には、中国、インド、日本、韓国、オーストラリア、その他のアジア太平洋地域諸国が含まれます。2023年には、精神疾患の有病率の上昇、医療費の増加、地域全体での医薬品開発、研究、医薬品承認活動の増加などの要因により、中国が収益の面で最大の地域市場となりました。さらに、一方でインドの市場は、2024年から2032年の予測期間にわたって最も速い速度で発展すると予想されています。
目次
Table of Contents
Chapter 1. Asia Pacific Antidepressant Drugs Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Asia Pacific Antidepressant Drugs Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product
2.3.2. By Depressive Disorder
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Asia Pacific Antidepressant Drugs Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Asia Pacific Antidepressant Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Asia Pacific Antidepressant Drugs Market Size & Forecasts by Product 2022-2032
5.1. Tricyclic Antidepressants
5.2. Selective Serotonin Reuptake Inhibitors
5.3. Serotonin Norepinephrine Reuptake Inhibitors
5.4. Monoamine Oxidase Inhibitors
5.5. Serotonin Antagonist and Reuptake Inhibitors
5.6. Others
Chapter 6. Asia Pacific Antidepressant Drugs Market Size & Forecasts by Depressive Disorder 2022-2032
6.1. Major Depressive Disorder
6.2. Obsessive-Compulsive Disorder
6.3. Generalized Anxiety Disorder
6.4. Panic Disorder
6.5. Others
Chapter 7. Asia Pacific Antidepressant Drugs Market Size & Forecasts by Country 2022-2032
7.1. China Antidepressant Drugs Market
7.1.1. Product breakdown size & forecasts, 2022-2032
7.1.2. Depressive Disorder breakdown size & forecasts, 2022-2032
7.2. India Antidepressant Drugs Market
7.3. Japan Antidepressant Drugs Market
7.4. Australia Antidepressant Drugs Market
7.5. South Korea Antidepressant Drugs Market
7.6. Rest of Asia Pacific Antidepressant Drugs Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Mayne Pharma Group Limited
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Aurobindo Pharma Ltd
8.3.3. Wockhardt Limited
8.3.4. Currax Pharmaceuticals LLC
8.3.5. Sun Pharmaceutical Industries Ltd
8.3.6. Zydus Lifesciences Limited,
8.3.7. Jiangsu Hengrui Pharmaceuticals Company Ltd.,
8.3.8. Takeda Pharmaceuticals Ltd
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
List of Tables
TABLE 1. Asia Pacific Antidepressant Drugs market, report scope
TABLE 2. Asia Pacific Antidepressant Drugs market estimates & forecasts by Country 2022-2032 (USD Billion)
TABLE 3. Asia Pacific Antidepressant Drugs market estimates & forecasts by Product 2022-2032 (USD Billion)
TABLE 4. Asia Pacific Antidepressant Drugs market estimates & forecasts by Depressive Disorder 2022-2032 (USD Billion)
TABLE 5. Asia Pacific Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Asia Pacific Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Asia Pacific Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Asia Pacific Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Asia Pacific Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Asia Pacific Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Asia Pacific Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Asia Pacific Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Asia Pacific Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Asia Pacific Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. China Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. China Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. China Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. India Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. India Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. India Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 21. Japan Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 22. Japan Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 23. Japan Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 24. Australia Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 25. Australia Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 26. Australia Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 27. South Korea Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 28. South Korea Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 29. South Korea Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 30.
TABLE 31. RoAPAC Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 32. RoAPAC Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 33. RoAPAC Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 34. List of secondary sources, used in the study of Asia Pacific Antidepressant Drugs Market.
TABLE 35. List of primary sources, used in the study of Asia Pacific Antidepressant Drugs Market.
TABLE 36. Years considered for the study.
TABLE 37. Exchange rates considered
List of figures
FIG 1. Asia Pacific Antidepressant Drugs market, research methodology
FIG 2. Asia Pacific Antidepressant Drugs market, market estimation techniques
FIG 3. Asia Pacific market size estimates & forecast methods.
FIG 4. Asia Pacific Antidepressant Drugs market, key trends 2023
FIG 5. Asia Pacific Antidepressant Drugs market, growth prospects 2022-2032
FIG 6. Asia Pacific Antidepressant Drugs market, porters 5 force model
FIG 7. Asia Pacific Antidepressant Drugs market, pestel analysis
FIG 8. Asia Pacific Antidepressant Drugs market, value chain analysis
FIG 9. Asia Pacific Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 10. Asia Pacific Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 11. Asia Pacific Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 12. Asia Pacific Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 13. Asia Pacific Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 14. Asia Pacific Antidepressant Drugs market, Country snapshot 2022 & 2032
FIG 15. Asia pacific Antidepressant Drugs market 2022 & 2032 (USD Billion)
FIG 16. Asia Pacific Antidepressant Drugs market, company market share analysis (2023)
